Regulatory Post-Marketing Surveillance (PMS) Study for ADACEL (Adsorbed Diphtheria, Tetanus Toxoids and Component Pertussis Combined Vaccine for Adult).
Phase of Trial: Phase IV
Latest Information Update: 06 Jan 2017
At a glance
- Drugs DTaP vaccine (Primary)
- Indications Diphtheria; Pertussis; Tetanus
- Focus Adverse reactions
- Sponsors Sanofi; sanofi pasteur
- 24 Mar 2016 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.
- 11 Jun 2010 New trial record